Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Carvedilol in the treatment of elderly patients with chronic heart failure Witte KK; Clark ALClin Interv Aging 2008[]; 3 (1): 55-70Chronic heart failure (CHF) is common, and increases in incidence and prevalence with age. There are compelling data demonstrating reduced mortality and hospitalizations with adrenergic blockade in older patients with CHF. Despite this, many older patients remain undertreated. The aim of the present article is to review the potential mechanisms of the benefits of adrenergic blockade in CHF and the clinical data available from the large randomized studies, focusing particularly on older patients.|Adrenergic beta-Antagonists/administration & dosage/pharmacology/*therapeutic use[MESH]|Aged[MESH]|Angiotensin-Converting Enzyme Inhibitors/pharmacology/therapeutic use[MESH]|Arrhythmias, Cardiac/prevention & control[MESH]|Carbazoles/pharmacology/*therapeutic use[MESH]|Carvedilol[MESH]|Chronic Disease[MESH]|Comorbidity[MESH]|Digoxin/pharmacology/therapeutic use[MESH]|Heart Failure/drug therapy/epidemiology/*prevention & control[MESH]|Humans[MESH]|Propanolamines/pharmacology/*therapeutic use[MESH]|Ventricular Dysfunction, Left/epidemiology[MESH]|Ventricular Remodeling/drug effects[MESH] |
